BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38142265)

  • 1. Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development.
    Nirgude S; Naveh NSS; Kavari SL; Traxler EM; Kalish JM
    Br J Cancer; 2024 Mar; 130(4):638-650. PubMed ID: 38142265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
    Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
    O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
    Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Hepatoblastoma and Wilms Tumor Leading to Diagnosis of Beckwith-Wiedemann Syndrome.
    Wolfe DM; Webster Carrion A; Masukhani MM; Oberg JA; Pavisic J; El-Ali A; Gupta M; Weng K; Glasser CL
    J Pediatr Hematol Oncol; 2023 May; 45(4):e525-e529. PubMed ID: 36730589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.
    Newsham I; Kindler-Röhrborn A; Daub D; Cavenee W
    Genes Chromosomes Cancer; 1995 Jan; 12(1):1-7. PubMed ID: 7534105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Beckwith-Wiedemann syndrome in children presenting with Wilms tumor.
    MacFarland SP; Duffy KA; Bhatti TR; Bagatell R; Balamuth NJ; Brodeur GM; Ganguly A; Mattei PA; Surrey LF; Balis FM; Kalish JM
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27296. PubMed ID: 29932284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS).
    Bliek J; Gicquel C; Maas S; Gaston V; Le Bouc Y; Mannens M
    J Pediatr; 2004 Dec; 145(6):796-9. PubMed ID: 15580204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor.
    Niemitz EL; Feinberg AP; Brandenburg SA; Grundy PE; DeBaun MR
    Am J Hum Genet; 2005 Nov; 77(5):887-91. PubMed ID: 16252245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular networks of hepatoblastoma predisposition and oncogenesis in Beckwith-Wiedemann syndrome.
    Sobel Naveh NS; Traxler EM; Duffy KA; Kalish JM
    Hepatol Commun; 2022 Aug; 6(8):2132-2146. PubMed ID: 35507738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome.
    Baskin B; Choufani S; Chen YA; Shuman C; Parkinson N; Lemyre E; Micheil Innes A; Stavropoulos DJ; Ray PN; Weksberg R
    Hum Genet; 2014 Mar; 133(3):321-30. PubMed ID: 24154661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1.
    Weksberg R; Nishikawa J; Caluseriu O; Fei YL; Shuman C; Wei C; Steele L; Cameron J; Smith A; Ambus I; Li M; Ray PN; Sadowski P; Squire J
    Hum Mol Genet; 2001 Dec; 10(26):2989-3000. PubMed ID: 11751681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of Beckwith-Wiedemann syndrome.
    Weksberg R; Squire JA
    Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms tumour in Beckwith-Wiedemann Syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines.
    Brzezinski J; Shuman C; Choufani S; Ray P; Stavropoulos DJ; Basran R; Steele L; Parkinson N; Grant R; Thorner P; Lorenzo A; Weksberg R
    Eur J Hum Genet; 2017 Sep; 25(9):1031-1039. PubMed ID: 28699632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
    Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP
    Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes.
    Russo S; Calzari L; Mussa A; Mainini E; Cassina M; Di Candia S; Clementi M; Guzzetti S; Tabano S; Miozzo M; Sirchia S; Finelli P; Prontera P; Maitz S; Sorge G; Calcagno A; Maghnie M; Divizia MT; Melis D; Manfredini E; Ferrero GB; Pecile V; Larizza L
    Clin Epigenetics; 2016; 8():23. PubMed ID: 26933465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
    Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
    Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
    Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
    Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome.
    Catchpoole D; Lam WW; Valler D; Temple IK; Joyce JA; Reik W; Schofield PN; Maher ER
    J Med Genet; 1997 May; 34(5):353-9. PubMed ID: 9152830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of Wilms tumor screening in Beckwith-Wiedemann spectrum.
    Mussa A; Duffy KA; Carli D; Griff JR; Fagiano R; Kupa J; Brodeur GM; Ferrero GB; Kalish JM
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3115-3123. PubMed ID: 31583434
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.